Loading…

Biofiltration methods for the removal of phenolic residues

Industrial effluents from the pharmaceutical industry often contain high concentrations of phenolic compounds. The presence of "anthropogenic" organic compounds in the environment is a serious problem for human health; therefore, it merits special attention by the competent public agencies...

Full description

Saved in:
Bibliographic Details
Published in:Applied biochemistry and biotechnology 2006, Vol.129-132 (1-3), p.130-152
Main Authors: Neves, Luiz Carlos Martins Das, Miyamura, Tábata Taemi Miazaki Ohara, Moraes, Dante Augusto, Penna, Thereza Christina Vessoni, Converti, Attilio
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Industrial effluents from the pharmaceutical industry often contain high concentrations of phenolic compounds. The presence of "anthropogenic" organic compounds in the environment is a serious problem for human health; therefore, it merits special attention by the competent public agencies. Different methods have been proposed in the last two decades for the treatment of this kind of industrial residues, the most important of which are those utilizing absorption columns, vaporization and extraction, and biotechnological methods. Biofiltration is a method for the removal of contaminants present in liquid or gaseous effluents by the use of aerobic microorganisms, which are immobilized on solid or porous supports. Although several bacteria can utilize aromatic compounds as carbon and energy source, only a few of them are able to make this biodegradation effectively and with satisfactory rate. For this reason, more investigation is needed to ensure an efficient control of process parameters as well as to select the suited reactor configuration. The aim of this work is to provide an overview on the main aspects of biofiltration for the treatment of different industrial effluents, with particular concern to those coming from pharmaceutical industry and laboratories for the production of galenicals.
ISSN:0273-2289
0273-2289
1559-0291
DOI:10.1385/ABAB:129:1:130